Not Signed In -
Estradiol Vaginal Ring |
Estring; Femring |
Clinical Trial: Efficacy and Tolerability in Thai Women
This study is not yet open for patient recruitment.
Verified by Schering AG, Germany September 2005
|
Purpose
To evaluate the safety, tolerability, and efficacy of Angeliq® in Thai post menopausal women with hot flushes and other climacteric symptoms.
| Condition | Intervention |
|---|---|
| Menopause | Drug: Estradiol Drug: Drospirenone |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Official Title: A Multi-Center, Open-Label, Non-Comparative Study Investigating the Efficacy and Tolerability of Angeliq® in Postmenopausal Thai Women with Vasomotor Symptoms Over Three 28-Day Treatment Cycles
Further Study Details:
Primary Outcomes: This study aims to evaluate the safety, tolerability and efficacy of Angeliq® in Thai postmenopausal women with hot flushes and other climacteric and urogenital symptoms.
Study start: September 2005
Eligibility
Ages Eligible for Study: 45 Years and above, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Postmenopausal women with hot flushes
Exclusion Criteria:
- Women with a contraindication for HRT
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00185328
Schering AG, Germany, Medical affairs, Region Asia/ Pacific +65 6511 6194
Thailand
Bangkok, 10330, Thailand
Bangkok, 10400, Thailand
Bangkok, 10700, Thailand
Chiang Mai, 50200, Thailand
Study chairs or principal investigators
Schering AG, Germany, , Medical affairs, Region Asia/ Pacific, Study Director, +65 6511 6194
More Information
Study ID Numbers: 309367
Last Updated: September 15, 2005
Record first received: September 12, 2005
ClinicalTrials.gov Identifier: NCT00185328
Health Authority: Thailand: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-20
Last Updated: September 15, 2005
Record first received: September 12, 2005
ClinicalTrials.gov Identifier: NCT00185328
Health Authority: Thailand: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-20
Resources
- Estradiol Vaginal Ring (Drug Digest)
- Estring (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
